Black Pearl Technology DACH Region

We have developed an artificial intelligence-based medical device (syringe), capable of extracting the highest possible amounts of beneficial proteins (growth factors) and stem cells from human and animal blood cells. The final product prepared by our innovation has proven clinical efficacy and safety for tissue regeneration in multiple human and animal chronic disorders. FDA registration is in progress. EU registration is in progress. Project Sector: Biotech, Health Tech, Medical Devices Project Stage: TRL stage 8-9